Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
Clinical trial NCT06180993 · RECRUITING
Trial details
- NCT number
- NCT06180993
- Sponsor
- Federico Martinón Torres
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-25
- Primary completion
- 2026-03-31
- Enrollment
- 42000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.